| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/13/2002 | US6432984 Cannabinoid receptor antagonists; treatment of obesity, drug addiction, alcholism, psychological, and eating disorders |
| 08/13/2002 | US6432976 Analgesics; side effect reduction |
| 08/13/2002 | US6432975 Aromatic alkylene azobicyclic compounds as nicotinic receptor antagonists; antidepressants; nervous system disorder treatment |
| 08/13/2002 | US6432974 Circadian rhythym, sleep, sexual, nervous system and psychological disorders; antidepressants, anxiolytic agents; drug abuse, drug dependence, and schizophrenia treatment |
| 08/13/2002 | US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 08/13/2002 | US6432954 Central nervous system disorders |
| 08/13/2002 | US6432952 Central nervous system disorders; antiinflammatory agents |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432940 Uses for androst-5-ene-3β, 17β-diol |
| 08/13/2002 | US6432687 Polypeptide amino acid sequence with immunoactive segments |
| 08/13/2002 | US6432404 Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies |
| 08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
| 08/13/2002 | CA2269947C Covalent polar lipid conjugates for targeting |
| 08/13/2002 | CA2202513C Allosteric modulators of the nmda receptor |
| 08/13/2002 | CA2134783C Use of remacemide for the treatment of parkinson's disease |
| 08/13/2002 | CA2060573C N-(aryloxyalkyl)heteroaryl-8-azabicyclo¬3.2.1|octanes, intermediates and a process for the preparation thereof and their use as medicaments |
| 08/13/2002 | CA2039120C Complexes of tiaprofenic acid, or of its insoluble or partly insoluble esters, with cyclodextrines or their derivatives |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061109A2 Yeast strains autonomously producing steroids |
| 08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | WO2002061095A1 Novel protein and dna thereof |
| 08/08/2002 | WO2002061074A1 Novel protein and dna thereof |
| 08/08/2002 | WO2002061052A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 08/08/2002 | WO2002061033A2 Transfection of human embryonic stem cells |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
| 08/08/2002 | WO2002060928A2 Medane genes and proteins |
| 08/08/2002 | WO2002060903A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060877A1 Imidazole derivatives |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060871A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| 08/08/2002 | WO2002060863A1 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060481A1 Methods for treating disease states comprising administration of low levels of antibodies |
| 08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | WO2002060478A1 Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
| 08/08/2002 | WO2002060471A2 Ligands for receptor-like protein tyrosine phosphatases |
| 08/08/2002 | WO2002060463A1 Lower alcohol-insoluble extract of hovenia dulcis var. koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same |
| 08/08/2002 | WO2002060462A2 Waay to obtain a extract with antidepressant and opioid antagonists properties and pharmaceutical products obtained from it |
| 08/08/2002 | WO2002060461A1 Blood brain barrier modulation using stressed autologous blood cells |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060445A1 Kappa opioid receptor ligands |
| 08/08/2002 | WO2002060444A1 Muscarinic receptor agonists |
| 08/08/2002 | WO2002060439A1 Analgesic and antiinflammatory drugs |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060435A1 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 08/08/2002 | WO2002060434A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/08/2002 | WO2002060428A2 Methods of using and compositions comprising (-)sibutramine optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060427A2 Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060424A2 Methods of using and compositions comprising sibutramine metabolites optionally in combination with other pharmacologically active compounds |
| 08/08/2002 | WO2002060423A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists |
| 08/08/2002 | WO2002060411A2 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 08/08/2002 | WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002060340A2 Method for identifying maxi-k channel blockers |
| 08/08/2002 | WO2002060339A2 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060234A2 Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof |
| 08/08/2002 | WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002030455A3 Agents for the treatment of viral infections |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002014269A3 2,4-substituted pyridine derivatives |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002007729A9 Non-sedating barbiturate compounds as neuroprotective agents |
| 08/08/2002 | WO2002005851A3 Enhancement of the action of central and peripheral nervous system agents |
| 08/08/2002 | WO2002005801A3 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2001098522A3 Positively-charged peptide nucleic acid analogs with improved properties |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001095899A3 Pharmaceutical compositions comprising cannabidiol derivatives |
| 08/08/2002 | WO2001092522A3 Human fgf-20 nucleic acids and polypeptides |
| 08/08/2002 | WO2001085150A3 Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001036419A9 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | US20020107375 Novel human lipocalin homologs and polynucleotides encoding the same |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107283 Halogenated 2-phenyl-1,2-ethanediol monocarbamate enantiomer |
| 08/08/2002 | US20020107280 Selective COX II inhibitor |
| 08/08/2002 | US20020107278 Substituted azepino[4,5b]indole derivatives |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |